Literature DB >> 21270164

Chromatin reassembly factors are involved in transcriptional interference promoting HIV latency.

Edurne Gallastegui1, Gonzalo Millán-Zambrano, Jean-Michel Terme, Sebastián Chávez, Albert Jordan.   

Abstract

The establishment of a stable reservoir of latently infected cells allows HIV to persist in the host. Usually, HIV infection of T cells results in integration of the viral genome, with a preference for regions in the human genome containing active genes, viral expression, and production of new viruses. However, in rare cases T cells become latently infected, and this is presumed to be due to a combination of two factors: integrated viruses are not efficiently transcribed and infected T cells revert to a resting memory state. HIV latency has been associated with provirus integration in regions of constitutive heterochromatin, gene deserts, or very highly expressed genes. We have investigated the transcriptional consequences of latent HIV integration into cellular genes and the involvement of chromatin reassembly factors (CRFs) in the transcriptional interference that a host gene exerts on the integrated cryptic HIV promoter. Chimeric transcripts containing sequences from the host gene and HIV can be detected, having been initiated at promoters of either the cell or the virus. Reactivation of HIV downregulates host gene expression. Cryptic promoters might remain inactive due to the repressive chromatin configuration established by CRFs during transcription elongation. Depletion of CRFs such as Spt6, Chd1, and FACT, or the histone chaperones ASF1a and HIRA, promoted HIV reactivation, concomitantly with chromatin relaxation and a decrease in general RNA polymerase activity. Overall, our results indicate that CRFs play a role in maintaining HIV latency by transcriptional interference when the provirus is integrated into an intron of a highly active gene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270164      PMCID: PMC3067836          DOI: 10.1128/JVI.01920-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

Review 1.  Controlling the elongation phase of transcription with P-TEFb.

Authors:  B Matija Peterlin; David H Price
Journal:  Mol Cell       Date:  2006-08-04       Impact factor: 17.970

2.  Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency.

Authors:  Isaure du Chéné; Euguenia Basyuk; Yea-Lih Lin; Robinson Triboulet; Anna Knezevich; Christine Chable-Bessia; Clement Mettling; Vincent Baillat; Jacques Reynes; Pierre Corbeau; Edouard Bertrand; Alessandro Marcello; Stephane Emiliani; Rosemary Kiernan; Monsef Benkirane
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

3.  HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications.

Authors:  Gary P Wang; Angela Ciuffi; Jeremy Leipzig; Charles C Berry; Frederic D Bushman
Journal:  Genome Res       Date:  2007-06-01       Impact factor: 9.043

Review 4.  A site to remember: H3K36 methylation a mark for histone deacetylation.

Authors:  Jung-Shin Lee; Ali Shilatifard
Journal:  Mutat Res       Date:  2007-01-21       Impact factor: 2.433

5.  Roles for Ctk1 and Spt6 in regulating the different methylation states of histone H3 lysine 36.

Authors:  Michael L Youdell; Kelby O Kizer; Elena Kisseleva-Romanova; Stephen M Fuchs; Eris Duro; Brian D Strahl; Jane Mellor
Journal:  Mol Cell Biol       Date:  2008-06-09       Impact factor: 4.272

Review 6.  Functional integration of transcriptional and RNA processing machineries.

Authors:  Shatakshi Pandit; Dong Wang; Xiang-Dong Fu
Journal:  Curr Opin Cell Biol       Date:  2008-04-22       Impact factor: 8.382

Review 7.  Coupling transcription and alternative splicing.

Authors:  Alberto R Kornblihtt
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

8.  Transcriptional interference antagonizes proviral gene expression to promote HIV latency.

Authors:  Tina Lenasi; Xavier Contreras; B Matija Peterlin
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

Review 9.  Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.

Authors:  Vincent Quivy; Stephane De Walque; Carine Van Lint
Journal:  Subcell Biochem       Date:  2007

10.  HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription.

Authors:  Xavier Contreras; Matjaz Barboric; Tina Lenasi; B Matija Peterlin
Journal:  PLoS Pathog       Date:  2007-10-12       Impact factor: 6.823

View more
  52 in total

1.  Identification of an ubinuclein 1 region required for stability and function of the human HIRA/UBN1/CABIN1/ASF1a histone H3.3 chaperone complex.

Authors:  Yong Tang; Aastha Puri; M Daniel Ricketts; Taranjit Singh Rai; Jason Hoffmann; Elise Hoi; Peter D Adams; David C Schultz; Ronen Marmorstein
Journal:  Biochemistry       Date:  2012-03-16       Impact factor: 3.162

2.  The viral protein Tat can inhibit the establishment of HIV-1 latency.

Authors:  Daniel A Donahue; Björn D Kuhl; Richard D Sloan; Mark A Wainberg
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

3.  RNAP II processivity is a limiting step for HIV-1 transcription independent of orientation to and activity of endogenous neighboring promoters.

Authors:  Katarzyna Kaczmarek Michaels; Frank Wolschendorf; Gillian M Schiralli Lester; Malini Natarajan; Olaf Kutsch; Andrew J Henderson
Journal:  Virology       Date:  2015-09-14       Impact factor: 3.616

Review 4.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

5.  p27Kip1 represses the Pitx2-mediated expression of p21Cip1 and regulates DNA replication during cell cycle progression.

Authors:  E Gallastegui; A Biçer; S Orlando; A Besson; M J Pujol; O Bachs
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

6.  Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.

Authors:  Julie K Jadlowsky; Julian Y Wong; Amy C Graham; Curtis Dobrowolski; Renee L Devor; Mark D Adams; Koh Fujinaga; Jonathan Karn
Journal:  Mol Cell Biol       Date:  2014-03-17       Impact factor: 4.272

Review 7.  Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.

Authors:  Uri Mbonye; Jonathan Karn
Journal:  Virology       Date:  2014-02-22       Impact factor: 3.616

8.  Sulfonation pathway inhibitors block reactivation of latent HIV-1.

Authors:  Jeffrey P Murry; Joseph Godoy; Amey Mukim; Justine Swann; James W Bruce; Paul Ahlquist; Alberto Bosque; Vicente Planelles; Celsa A Spina; John A T Young
Journal:  Virology       Date:  2014-10-11       Impact factor: 3.616

Review 9.  Understanding HIV latency: the road to an HIV cure.

Authors:  Matthew S Dahabieh; Emilie Battivelli; Eric Verdin
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

Review 10.  Epigenetics, drugs of abuse, and the retroviral promoter.

Authors:  Jasmine Shirazi; Sonia Shah; Divya Sagar; Michael R Nonnemacher; Brian Wigdahl; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-12       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.